Broadview Ventures

Broadview Ventures

Boston, Massachusettsbroadviewventures.org

Overview

Broadview Ventures is a mission-driven investment organization that makes targeted investments in early-stage companies to accelerate the development of innovative therapeutics, devices, and diagnostics for cardiovascular disease and stroke. The firm invests in companies across North America, Europe, and Israel.

Year Founded

2009

Portfolio Companies

22

Investments

CompanyDateStageLead
FineHeartJan 2026Series CCo-investor
AtaCor MedicalOct 2025Growth EquityCo-investor
Mosanna TherapeuticsJun 2025Series ALead
Alleviant MedicalJan 2025Early FundingCo-investor
Alveron PharmaDec 2024SeedLead

Key People

Benjamin Kreitman

Principal

David Prim

Principal

Hewmun Lau

Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2009

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.